Halozyme Therapeutics, Inc.
$HALO
Public valuation for Halozyme Therapeutics, Inc. (HALO). Fair value, signal, and key metrics — no sign-in required.
Current Price
$110.40
Fairly Valued
Fair Value Estimate
$112
💎
Value
Established company trading at a low multiple
Analyst Consensus
Target: $99.56
10% lower than current
Key Metrics
Market Cap
$12.5B
Forward P/E
11.4x
Operating Margin
59.8%
Revenue Growth
47.4%
PEG Ratio
1.07
Get free watchlist alerts
Join the waitlist for valuation updates on $HALO and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.